A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Status:
Completed
Trial end date:
2013-06-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of esketamine compared with placebo in
improving symptoms of depression in patients with treatment resistant depression.